From the outset, since joining the fight against AIDS, Solthis has played its part in advocating for access to treatments, fighting against discrimination and promoting the right to health, which has always been an important part of the work of the associations. Additionally, we have noted the emergence of new areas of need, relating to the running of large international institutions, the necessary popularization of scientific research and the international networking.
Through our dual focus, both scientific and ground-based, Solthis aims to develop policies and practices in order to defend equal access to healthcare for all. Over the years, Solthis has developed expertise in team advocacy, with three main objectives:
Defending equal, universal access to healthcare.
Respecting the rights of patients, financing health programmes, fighting to improve access to medication and healthcare products (treatments for hepatitis C, viral load tests to monitor HIV patients…), fighting for human rights and against stigmatizing and discrimination – these are all areas in which we act as advocates. Solthis also defends the place of healthcare on the international agenda, notably by means of Coordination SUD's Health Commission, of which we are at the forefront, and by monitoring the financing of Public Development Aid (PDA).
Continuing to develop the practices and policies of aid
By promoting, for example, the widespread use of techniques or combination therapies, based on a technical analysis of their efficacy and efficiency.
Participating in improving the adequacy of international aid programmes (financial and technical support) on the ground
Solthis positions itself between field workers and international policy-makers in order to improve the circulation of information and the shape of current financial and technical partnerships.
Furthermore, we see advocacy as a method of intervention which complements other forms of action, first of all internally, where it ties in with operational research and reinforces capabilities.
Externally, Solthis works on the ground as an agency dedicated to advocacy based on identified and documented facts (“evidence-based” advocacy), in harmony with public and media engagement initiatives and with the work of think-tanks from other organizations.
Our work to mobilize aid and provide universal access to healthcare
On the ground, Solthis' teams work with national partners and health associations to develop advocacy work, particularly on questions relating to the right of access to healthcare.
In Paris, Solthis coordinates the Health Commission of NGO members of Coordination SUDand cooperates with French associations in the fight against HIV/AIDS, to promote healthcare and international solidarity, as well as with global institutions and organizations such as the Ministry of Foreign Affairs, UNAIDS, and Global Fund, among others.
Solthis participates in a number of initiatives which aim to challenge public powers in order to defend the funding of international health programmes and the access to quality healthcare for all.
Parliamentary studies trip: in partnership with Global Health Advocates France, Solthis co-organized a trip to Nigeria in June 2014 on the theme of child health. Its purpose was to make the two French deputies and one French senator there aware of improvements in public health which enable public aid for the development of health in southern countries, although France has continued to decrease this budget.
See the two mini-reports written during this trip:
In order to create advocacy based on facts, ground-based missions have been organized in four of the countries in which Solthis works, with the goal of bringing together all of the players involved in the implementation of World Funds programmes (main and secondary recipients, national programmes, CCM, technical and financial partnerships…). Solthis' national teams have also shared their findings, their experience on the ground and their recommendations. Meetings have taken place with teams from the World Fund in Geneva and Solthis participated in two Administrative Councils of World Funds in 2014 (in Jakarta and Montreux). 140 people were interviewed in total. The report took into account 6 case studies, and almost 30 recommendations were made: “Risk Management in Fragile States: Health First! Increase the Efficiency of Grants from World Funds” (In French). This was widely distributed around the time of the Administrative Council of World Funds in November 2014 and was presented to a number of delegations (most notably the French delegation, the African delegations, and the delegations of northern and southern NGOs).
Many media outlets and internet sites also received this information.
The substantial feedback commended this groundwork for highlighting the difficulties on the ground in a concrete, documented manner. The end of the year was devoted to strengthening links with contacts made at the AC and in following up the recommendations of the report.
This French – English translation was done by the translator Hannah Slater and proofread by Katie McIvor for the PerMondo project that involves providing free translations for NGOs. This initiative is sponsored and run by the translation agency Mondo Agit
“Managing Risk in Fragile States: Putting Health First!
Optimising the Efficiency of the Global Fund's Grants”
This evidence-based report is the result of a work over several months, including 4 missions (Guinea, Mali, Niger and Sierra Leone) and interviews with 140 stakeholders. Through this work, we identified bottlenecks in the implementation of the Global Fund's grants in the field, showing that the Global Fund's Risk Management Policy is not well-adapted to fragile states. The additional safeguard measures which have been put in place by the Secretariat after the investigations of the Office of the Inspector General were meant to mitigate the financial risks and to reassure donors. However, experiences in challenging operating environments clearly show that these measures are mainly focused on financial risks and have caused significant malfunctions that jeopardise both the impact and the sustainability of the programmes.
In order to make progress and to cope with the challenges specific to fragile states, we think it is now time for the Board members and the donors of the Global Fund to opt for an ambitious and innovative policy, which would put financial risk at its proper place: behind risks to public health.
The main recommendations we are addressing in the report aim to place the public health risk at the centre of the mechanism, by:
Improving the balance between the analysis and the management of the different risks.
Simplifying and clarifying the control procedures: limit the number of contractors and the levels of validation.
Defining indicators or objectives for terminating additional safeguard measures to encourage appropriation and capacity building.
Investigating the possibility of an increased presence of the Global Fund in the field, by missions of several weeks or several months.
Adapting the indicators and procedures of performance-based funding and accountability measures to fragile states.
27th of June 2014, Solthis will held its annual Scientific Day in the presence of its field teams.
Such as every year Solthis also invites its technical and financial, medical, institutional, associative partners.
Discussions will focus on three major themes :
- HIV and infectious diseases (hepatitis, tuberculosis and neurological opportunistic infections)
- Mother and Child Program, a public health priority in sub-Saharan Africa
- Key Populations: crossed viewpoints
On 28th june at the Pitié-Salpêtrière, Sothis organized its Scientific Day in the presence of its field teams. Medical, institutional, associative, technical and financial partners were present too. Discussions focused on 5 topical issues : paediatrics, hepatitis C, virological monitoring, Global Fund and monitoring-evaluation.
Special edition of Transcriptases magazine (spring 2012)
Création d’un hôpital de jour à l’Hôpital National de Niamey : Le vécu des patients sur l’évolution du continuum de soins
Autor(s) : S. Mohamadou, M. Idé, G. Lurton, E. Adehossi, B. Madougou, H. Toure, E. Guillard, F. Huber, C. Dézé, S. Diallo
Download the posterMettre en œuvre un programme public d’éducation thérapeutique des patients vivants avec le VIH dans les centres prescripteurs d’un pays à ressources limitées : l’expérience du Niger
Autor(s) : Fati Maiga, Agnès Certain, Hadiza Baoua, Mamane Harouna, Caroline Gallais, Oumarou Seybou, Souleymanou Mohamadou, Pierre Teisseire, Sanata Diallo, Florence Huber, Sophie Calmettes, Etienne Gillard
Download the posterPrévalence du risque cardiovasculaire évalué d’après les mesures des plis cutanés - Étude transversale au Niger
Autor(s) : V. Moyà Alvarez I. Baragé, Y. Hanki, I. Dillé, F. Huber, G. Lurton, Y. Madec
Download the posterLa difficulté du suivi des enfants infectés par le VIH au CHU Gabriel Touré de Bamako (Mali)
Autor(s) : M. Sylla, H. Coulibaly, F. Dicko-Traoré, A. Akondé, G. Lurton, A. Diakité, A. Diallo, C. N'Diaye, M. Traoré, S. Touré, N. Koné, T. Sidibé
Download the posterUne prévalence préoccupante de résistances transmises aux antirétroviraux chez les hommes ayant des relations sexuelles avec des hommes à Madagascar
Autor(s) : S. Andriantsimietry, F. Lamontagne, M. Randria, M.L. Chaix, L. Pizarro, R.L. Razanakolona, C. Rouzioux
Download the posterEnjeu de la prévision des besoins avec des données faibles : expérience d'utilisation de projections par scénarios en Guinée
Autor(s) : G. Lurton, M. Diallo, E. Guillard
Download the posterComparaison de l'apport des examens microbiologiques au diagnostic de la tuberculose chez les PVVIH au Niger. Données préliminaires d'une étude interventionnelle
Autor(s) : M. Idé, S. Mohamadou, A. Yacouba, O. Seybou, R. Abba, S. Mamadou, F. Lamontagne, I. Diallo, G. Lurton, F. Huber, S. Diallo
Download the posterLe défi de la coordination des approvisionnements : l'exemple réussi du "Groupe Approvisionnement" au Niger
Autor(s) : Z. Ankourao, I. Mato, A. Messan Ganfled, S. Ouvrard, E. Guillard
Download the poster
Consolider l’apprentissage des connaissances thérapeutiques sur le bon usage des traitements ARV par les professionnels de santé à partir d’un jeu de carte innovant : « La thérapeutique VIH en jeu»Author(s) : Charlotte Dézé, E. Guillard, S. Ouvrard, M. Diallo, P. Autret
Dealing with uncertainty the challenge of long term projections in low data resources countries
Author(s) : M. Diallo, G. Lurton, E. Guillard
Connaître son virus, connaître son épidémie : contribution de la virologie moléculaire à la compréhension de l’épidémie VIH
Author(s) : Franck Lamontagne
Presentation non available
Identification d'un cluster viral à l'origine d'un taux élevé de résistance primaire aux ARV au niveau national : le cas singulier de Madagascar
Author(s) : F. Lamontagne, S. Andriantsimietry, M.L. Chaix, M. Randria, J. Nely, C.B. Ramamonjisoa, J.S. Lalao, H. Rahasana, G. Lurton, L. Pizarro, F. Huber, R.L. Razanakolona, C. Rouzioux
Download the posterBilan de 10 ans de prise en charge pédiatrique au CHU Gabriel Touré de Bamako (Mali)
Author(s) : M. Sylla, H. Coulibaly, F. Dicko-Traoré, A. Akondé, G. Lurton, A.A. Diakité, A. Diallo, C.N'Diaye, M. Traoré, S. Touré, N. Koné, T. Sidibé
Download the posterHétérogénéité des pratiques et difficultés diagnostiques de la tuberculose chez les personnes infectées par le VIH à Niamey, Niger
Author(s) : R. Abba, F. Lamontagne, M. Souleymanou, O. Seybou, Y. Hanki, S. Diallo, G. Lurton, S. Mamadou
Download the posterManifestations neurologiques chez les patients hospitalisés au CHU de Conakry : un diagnostic à améliorer compte tenu de leur impact majeur sur la mortalité
Author(s) : G. Choaken, R. Vilain, F. Lamontagne, G. Lurton, M. Barry, A.A.S. Diallo, L. Laho, D. Mandiou, E. Papot, F. Huber, M. Cissé
Download the posterOffrir systématiquement le dépistage VIH en milieu de soin : une urgence de santé publique
Author(s) : R. Vilain, G. Choaken, F. Lamontagne, G. Lurton, M. Barry, A.A.S Diallo, L. Laho, D. Mandiou, E. Papo, M. Cissé, F. Huber
Download the posterAméliorer la prévention de la transmission du VIH de la mère à l'enfant en Guinée selon une démarche participative d'accompagnement au changement
Author(s) : C. Dézé, H. Yous, A. Keita, T.C. Sidibé, S. Calmettes, N. Barsacq, F. Lamontagne
Download the poster
Prof. C. Katlama, Prof. G. Brücker et S. Calmettes
On the occasion of its General Assembly, Solthis held Wednesday, July 6 at the Pitié-Salpêtrière, the 4th day meeting. Teams Solthis and partners in the field were present, especially from Mali, Guinea, Niger and Haiti.
The presentations are available below on this page.
HIV testing: a challenge?
Y. Yazdanpanah, F. Huber, R. Tubiana, M. Idé
At the "Test and Treat", screening is an important theme in African contexts, as in Western countries. Also, the first workshop of the Scientific Day Solthis it was dedicated, moderated by Dr. M. Ide (Niger) and Dr. R. Tubiana (Paris).
In his introduction, Dr. F. Huber (Solthis) presented the technical aspects of "rapid tests" raising the question of the limits of these tests, and the problem of lack of due process and the frequent inability to meet the temperature conditions recommended by the suppliers. This presentation was followed by a review of different screening strategies and the historical evolution of paradigms: the screening called "voluntary" to "provider-initiated testing for carers" as advocated by WHO and the various authorities health. Aspects of "cost effectiveness" of screening were then analyzed by Prof. Y. Yazdanpanah (Tourcoing). Dr. F. Lamontagne (Solthis Guinea) and Prof. M. Cisse (Guinea) have supported these statements by the West African experiences Solthis on screening in the care environment "opt out". If this type of screening "at the initiative of the caregiver" has made great advances in PMTCT or in tuberculosis centers, much remains to be done in other departments of medicine, where a high proportion of patients is not detected, not supported. Mobilization on this issue is more strategic than ever.
Despite the investment of Solthis on supply issues (ARV, all health products ...), stock-outs, especially for ARVs, are still common in the field and directly threaten the health of patients. The session dedicated to these issues was conducted by two doctors Dr. B. Diallo (Mali) and Dr. PM Girard (Paris).
E. Guillard (Solthis Pharmacy Manager) said the overall functioning of the supply before presenting the main causes that lead to situations of stockouts. The threat of disruption of Guinea in February 2011 was taken as an example to highlight the failures at different levels of decision making. Teams in the field of pharmacy Solthis and their partners then described their daily actions, emphasizing the mode of intervention or Solthis tools developed together, such as coordinating groups and committees for monitoring supplies, tables edge compilation, analysis, alerting, quantification tools ... Finally, J. Langlois (Sidaction) and F. Foguito (TAW), representing civil society, concluded the session by the role of associations to fight against breakage, and more widely to improve the quality of care.
Prof. V. Calvez (Pitié-Salpêtrière, Paris) presented the situation of primary resistance throughout the world, before recalling the consequences attributable to virological choice of first-line treatments. He raised the problem of low genetic barrier of molecules commonly used in countries with limited resources (especially NNRTIs), especially when access to viral load is small or nonexistent.
This session, moderated by Prof. M. Cisse (Guinea) and Dr. G. Breton (Paris), addressed the issue of retention of patient care in the circuit, through various initiatives. After a general introduction of G. Lurton (Solthis), Dr. M. Ide (National Hospital of Niamey) lamented the difficulties of long-term monitoring of HIV patients in Niger, based on the experiences of ambulatory treatment center and day hospital in Niamey. The experience of Medecins du Monde, supporting marginalized populations in integrated centers in Asia, was reported by Dr. N. Luhman. Finally, Dr. Claude Pean, Haitian Institute Pereo Fame, introduced the operation of the center of Port-au-Prince, who has built an international program based on improving the encrypted performance.
The Scientific Days of Mali experts have gathered several members of the Working Group Solthis: Christine Katlama, Roland Tubiana and Gilles Brucker. Solthis co-organized the National Day which brought together over 300 Malian professionals involved in the fight against HIV. For Solthis and its partners, it was an opportunity to present the results of the management and discuss immunological and therapeutic advances.
HIV prevalence and renutrition in children hospitalised for severe malnutrition in Niamey (Niger)Autor(s) : R. Maiga-Mamadou, W. Alkassoum, M. Hamadou, A. Abdou, C. Pizzocolo, S. Diallo, C. Dezé, V. Moya-Alvarez, F. Huber, Y. Madec
Evolution de la prise en charge du VIH à Ségou entre 2003 et 2009
Author(s) : L. Diakité, D. Katilé, , N. Diallo, A. Doumbia, MS. Koné, B. Coulibaly, A. Sidibé, Y. Coulibaly, A. Akondé, G. Lurton, F. Huber
Download the presentationEvaluation de la mise en place du dépistage et de la prise en charge du VIH au centre antituberculeux Carrière, à Conakry (Guinée)
Author(s) : LM. Camara, B. Bah, D. Touré, P. Kourouma, L. Hajouji, C. Katlama, F. Huber, O. Sow
Download the presentationDélégation de la prescription des antirétroviraux aux paramédicaux dans la PTME à Ségou (Mali)
Author(s) :A. Doumbia, A. Sidibé, AT. Traoré, A. Akondé, F.Z.T. Sangaré, DC. Traoré, M. Maiga, AM. Soumaré, F.D. Cissé, SD. Naman, G. Lurton, C. Katlama, F. Huber
Download the presentationCharge virale en routine dans un pays à ressources limitées : le cas du Niger
Author(s) : Dr Hanki, H. Yahayé, S. Mamadou, I. Aboubacar, R. Ali Maazou, I. Dillé, C. Dézé, S. Diallo, F. Huber, M. Amadou, F. Maïga
Download the presentationL'épidémiologie des perdus de vue dans les programmes VIH/SIDA
Author(s) : E. Poulet, M. Pujades-Rodriguez
Download the presentationL'approche anthropologique des ruptures de suivi médical des personnes vivant avec le VIH : l'exemple de Kayes (Mali)
Author(s) : S. Carillon, V. Petit
Download the presentationLes patients sous ARV perdus de vue : l'expérience de l'ONG WALE
Author(s) : D. KatiléDownload the presentation
This number is published on the occasion of the Francophone Conference, Solthis revisits some of which abstracts will be presented.Interviews with Himmich Pr, Pr Pr Delaporte & Brucker, the co-chairs of the Conference
Screening: The déspistage initiated by the Caregiver and the rapid screening tests
Biological monitoring: Reactions of experts to study the DART
Folder on the phenomenon of Lost to: What tools? what response?
Tuberculosis: The MDR / XDR and Practical Guide to WHO in its fight against infections
Folder on the new WHO recommendationsPharmacy management tools
The Scientific Days, organized by the ULSS and CMT, in partnership with Solthis and GIP Esther, took place on 2 and 3 October 2009 in Niamey in the presence of Professor Katlama (Solthis President), Prof. Brucker (Treasurer Solthis and CEO of Esther) but also of Dr Kassi (Ivory Coast) and Professor Toure (Senegal).
More than 250 physicians, health professionals, representatives of the fight against HIV, tuberculosis in Niger attended these days. Many topics on Chess therapeutic Opportunistic Infections, PMTCT, Accidents of exposure to blood and the delegation of tasks were discussed.
Over a hundred people came to attend the Scientific Solthis Day on June 26. Players on the field of SOLTHIS, France or Paris, they met for the highlight of the association. Also, many distinguished guests were present: representatives of national and international institutions, the Global Fund, civil society actors ... Today, all teams SOLTHIS wishes to thank those who were able to attend this day to the quality of exchanges, the wealth of information and their demonstrated interest in our actions.
Scientific Day of Solthis is also an opportunity to give voice to field to present the projects implemented and to share their thoughts on the challenges of HIV disease. See you in 2010!
Proceedings of the Round TableWhat future for international funding of HIV programs?
In the current economic crisis and crisis funding, SOLTHIS wanted to set up a reflection on this vast subject. The roundtable, chaired by Professor Gilles Brucker, gave rise to two questions, firstly that of continuous funding for the fight against HIV and the effectiveness of such funding. This debate was thus the occasion for Prof. Patrice Debré, new Ambassador in charge of the fight against HIV AIDS, to outline the challenges and the strategy it intends to introduce. Dr. Florence Veber, Assistant Director for Health and Human Development (MFA) has expressed his current thinking on innovative financing and recalled in place of the fight against HIV in health policy. Representatives of civil society were also at the table. Marie-Alexia Delerue, of Action for Global Health, called for a mobilization of governments for development of new sources of funding in addition to their official development assistance. As for Khalil Elouardighi, Coalition of More, he warned of the serious short-term decline in funding from the Global Fund, particularly for patients néceisstant treatment of second and third line.
Prof. Patrice Debré: Patients and international partnerships
Prof. Patrice Debré is the new Ambassador in charge of the fight against HIV / AIDS and infectious diseases.There is also a co-founder of Solthis.
Professor Debre presented the characteristics of the epidemic: 33 million people infected with HIV, 2.7 million new infections per year, two million deaths 75% in Saharan Africa. A disease that affects both women that man ... In countries é low or middle income, the access to ARVs is limited: only 31% of global demand for ARVs are covered. .. HIV was the illness that led to the concept of "Global Health" to emerge, this awareness of global health has led to considerable social and political commitments for which new resources and new funds were needed .
Then, the Ambassador outlined the contribution e franéaise the fight against pandemics based financing channels in 2007:
- For HIV: 363 million euros, 20 million for bilateral (AFD, Esther, ... AT MFA) and 26 million for Research (ANRS, IRD, CNRS ...).
- For malaria: 100 million for multilateral and bilateral for zero.
- For TB: 31 million for multilateral and bilateral 3 million for.
Finally, Professor Debré expressed challenges in the fight against HIV at international level:
1. Harmonization of the Governance of International Health
2. Cooperation among the multilateral organizations
3. Complementarity between the bilateral and the multilateral
4. European dimension
5. Support in general
6. Integrated approach between basic and clinical research, opening e other areas such as agronomy
7. Multiplication of innovative financing
Dr. Florence Veber is currently in charge of the Sub-Directorate of Health and Human Development of the Ministry of Foreign Affairs and European.
Dr. Florence Veber presented the new organizational structure of Ministry of Foreign Affairs and European set up to be in phase with the emergence of global issues like climate change or pandemics. She outlined the three main directions:
1. Administrative direction
2. Diplomatic lead (geographical division)
3. Overall direction of globalization development, partnerships and development.
This new direction is divided into four sub-directorates including the Directorate of global public goods including climate, natural resources (forests and water), food security and health and human development. Led by Dr. Veber, this sub-directorate deals with issues of health but also education, employability, gender equality, migration, demography and social protection.
To date, this sub-department is particularly sought for the monitoring of commitments in the multilateral franéais since 75% of the budget of the health cooperation through multilateral channels. She is in charge of policy definitions, the Operational being managed by AFD (Franéaise Development Agency). Moreover, the strategy of cooperation policy for health should be reviewed to the end of 2009 with the participation of stakeholders. This new team wants to offer stakeholders greater access and transparency to the data field to promote shared approaches among other NGOs and the Ministry.
Dr. Veber has shared his thoughts of two topics:
1. Consequences of funding for HIV / AIDS on strengthening health systems?
2. Efficiency and use of innovative financing in health?
Marie-Alexia Delerue: Health Care Financing
Marie-Alexia Delerue is responsible for advocacy at Medecins du Monde, a member of the NGO network European Action for Global Health.
Marie-Alexia Delerue presented the evolution of financing Development assistance for health:
- International: 4-fold increase between 1990 and 2007;
- At European level: 58% increase from 2001 e 2007;
- In France: 4-fold increase between 2000 and 2007;
- Sources: Public sources of funds, but increasingly the private / philanthropic (26.7% of total international aid health in 2007);
- Channels: increased multilateral channel (GFATM, GAVI).
If this international movement, ed through increased international funding, has achieved considerable progress in terms of health (reduction of child mortality, increasing the number of patients having access to ARVs ...), we find that health issues in the South are immense: the eight Millennium Development Goals (MDGs), who increased the least are those for e health. Funding and predictability are still insufficient.
In the current economic crisis, health indicators are threatened. The WB report on the global crisis provides that if any international response is urgently adopted to support developing countries, approximately 200 000 e 400 000 children under 5 years and more will lose their lives each year. It is therefore fondammental that donors meet their financial commitments in favor of health.
Today, NGOs are calling on international donors and governments in the South:
- Putting health at the heart of development policies (for developing countries, have 15% of their health budget e)
- Respect the commitments made by donors in the framework of the G8
- Promote the strengthening of health systems
- Develop new funding sources, including quickly implement the tax on currency transactions, which could bring in $ 40 billion by annnée and would therefore make a real difference in terms of scale of development finance and accelerate the progress of health indicators. Innovative financing must be additional e the official development assistance and truly predictable.
The 15th International Conference on AIDS and Sexually Transmitted Infections in Africa was held from 3 to 7 December 2008 in Dakar. It was an important time to take stock of the various initiatives in the fight against HIV / AIDS implemented in Africa.
For Solthis, this conference was an opportunity to present at international level, the work done for 5 years, its action on the ground every day, in direct support of care teams and national health policies. Several papers were presented by members of Solthis, a satellite-symposium was organized, open to the public of broadcasts in partnership with RFI have been put in place ... Every day, the teams were present at booth to greet visitors and answer their questions.
An oral presentation
View lost in Segou (Mali) What drives HIV patients who receive free care to give it up and leave the circuit centers of care?
To try to answer this question, Gregory Lurton, project manager of information systems, presented the investigation into the missing=in Segou and the work on information system support.
View lost in Segou, Gregory Lurton
Solthis' teams participated to the drafting of several posters presented at the congress.
Solthis, in partnership with the Respasi (African Network of Practitioners Providing the Medical Management of People Living with HIV AIDS), held a symposium on satellite support transfronalière of phas in Africa. Indeed, more and more patients living with HIV / AIDS are required to travel within Africa. These movements can compromise the quality of their support for issues related to harmonization of the provision of care, equity of access to care, monitoring and tracking of patients and the vulnerability of these patients.
Solthis and the issuance of Priority Health Hédon Claire, broadcast daily on RFI, have partnered to offer the public a forum of ICASA. A recording booth in the center of the village association was installed to host two shows.
Priority health - Thursday, december 4
The first issuance took hold of the XV ICASA for an update on the current state of research on treatments against HIV: what the state of research in the North and the South?
Professor Jean-Francois Delfraissy, Director of the ANRS, Professor Papa Salif Sow, Co-Chair of the Scientific Program Committee of the XV ICASA and Dr Diallo Sanata, medical coordinator in Niger Solthis met to take stock of research and its implementation in countries in Africa. They answer questions from the public and Claire Hédon of ICASA.
Priority health - Friday, december 5
What about access to treatment in Africa, what is the state of care for patients living with HIV / AIDS?
In a second issue carried out as part of the XV ICASA, Claire Hédon pose his questions to Professor Christine Katlama of Pitie Salpetriere Hospital in Paris, and President of Solthis, Dr. Alain Akondé, Medical Coordinator for Solthis Mali and Pr Serge Eholié CHU Treichville in Abidjan.
Les perdus de vue de la région de Ségou, au Mali
Author(s) : G. LurtonDownload the presentationPrise en charge transfrontalière des PVAVS : le point de vue du soignant
Author(s) : S. DialloDownload the presentationMigrations transfrontalières en Afrique de l'Ouest : le regard des sciences sociales
Author(s) : S. TchiombianoDownload the presentationContinuum des soins et politique d'accès aux traitements des IST/VIH/SIDA dans les cinq pays du Corridor Abidjan-Lagos
Author(s) : J. KoffiDownload the presentationLa PEC transfrontalière des PVVIH : recommandations
Author(s) : S. DialloDownload the presentationQuestions posées et enjeux de l'adoption d'une loi spécifique sur le VIH/sida : le cas du Niger
Author(s) : S. TchiombianoDownload the presentation
HIV/AIDS care and follow-up on a national scale in low resource settings: experience of the Niger Initiative on Antiretroviral Access (INAARV), NigerAuthor(s) : M. Ide, Y. Madec, M. Boubacar, E. Adehossi, C. Dezé, GM. Lawal, O. Amadou, S. Diallo, C. Pizzocolo, IA. Touré, S. Mamadou, C. Katlama and the National Technical Committee
Download the presentationPilot cell comprehensive care: a multidisciplinary service orientation and listening PHAs, NigerAuthor(s) : A. Alzouma, C. Dezé, B. Sabo, M. Bako, S. Maman, I. Mourtala, M. Goundara, F. Djermakoye, M. Ide, F. Aeberhard
Download the presentationThe impact of prior recourse to traditional medicine on the out-of-pocket expenditure of HIV/AIDS patients in NigerAuthor(s): S. Walker, S. Tchiombiano, A. Maiga, R. Hassane, M. Idé, AH. Souna, V. Bignon, O. Weil, L. Pizarro
Download the presentationIncidence and risk factor for tuberculosis (TB) in HIV patients on ART, Niger
Author(s): A. Foucher, Y. Madec, S. Diallo, Z. Thiousso, I. Dillé, S. Gambo, HA. Souna, A. Oumarou, A. Manou, GM. Laoual, Al. Touré, C. Pizzocolo, L. Pizarro, A. Fontanet
Download the presentationDecentralized access to triple therapy and viral load monitoring in West Africa (Mali)Author(s) : A. Akondé, Y. Madec, AB. Dicko, I. Haidarra, I. Katile, B. Diarra, M. Kye, A. Doumbia, C. Pizzocolo, C. Katlama and the Segou Medical Technical Committee
Download the presentationA method of HAART decentralization in rural areas: Solthis' experience in Segou (Mali)Author(s) : P. Teisseire, A. Akondé, C. Pizzocolo, S. Calmettes, S. Dalglish, N. Bodo, L. Pizarro
Download the presentationPrevention of mother-to-child transmission of HIV (PMTCT) in a rural setting : the experience of the Segou region in MaliAuthor(s) : CD. Traoré, A.akondé, T. Samake, T. Traoré, Y. Coulibaly, O. Coulibaly, A. Sidibé, D. Germanaud, Z. Traoré, A. Maiga, AG. Marcelin, C. Pizzocolo, C. Katlama and the Segou Medical Technical Committee
Download the presentationAppraisal of treatment modification in HIV patient follow-up in the region of Segou (Mali)Author(s) : J. Landier, A. Akondé, C. Pizzocolo, I. Haidara, M. Drabo, L. Pizarro, A. Fontanet, C. Katlama, Y. Madec
Download the presentationEtude virologique chez des sujets VIH-1 suivis à MadagascarAuthor(s) : F. Lamontagne, S. Andriantsimietry, ML. Chaix, JP. Viard, M. Randria, J. Nely, S. Randriamampionona, C. Aguilar, S. Royer, C. Pizzocolo, LR. Razanakolona, C. Rouzioux
Download the presentation
International AIDS Conference – Mexico City, August 2008
HIV-infected children in the context of the Niger Initiative on Antiretroviral Access (INAARV), Niger (West Africa)Author(s) : R. Abdoulaye-Mamadou, I. Adehossi, Y. Madec, C. Dezé, W. Alkassoum, M. Mahamane, I. Daouda, M. Amadou, D. Germanaud, C. Pizzocolo, S. Mamadou, C. Katlama and the National Technical Pediatric Committee
Download the presentationLooking for lost to follow-up patients: experiences of Segou (Mali)Author(s) : G. Lurton, A. Akondé, Y. Madec, P. Teisseire, T. Traore, B. Touré, D. Cissé, C. Koumaré, C. Pizzocolo, L. Pizarro, C. Katlama, and the Segou Medical Technical Committee
Download the presentation
L'observance au Niger : une approche socio-anthropologique utile à l'action
Author(s) : JP. Olivier de Sardan, A. Diarra, A. Moumouni
Download the presentationEvaluation des patients VIH/Sida ayant bénéficié d'un traitement ARV au sein de l'INAARV (Initiative Nigérienne d'Accès aux Antirétroviraux) : résultats à 2 ans
Author(s) : M. IdéDownload the presentationInfections opportunistes (IO) chez les patients infectés par le VIH traités par ARV au sein de l'INAARV (Initiative Nigérienne d'Accès aux Antirétroviraux)
Author(s) : B. MadougouDownload the presentationSolthis : une ONG médicale au service des pays du Sud
Author(s) : L. PizarroDownload the presentation
Evaluation d'un programme d'accès décentralisé aux antirétroviraux au Mali
Author(s) : AB. Dicko, MH. Maiga, A. Akondé, Y. Madec, C. Pizzocolo, le Comité thérapeutique de Ségou et le groupe de travail Solthis
Download the posterMise en place de la numération des lymphocytes T CD4+ par cytométrie de flux et suivi immunitaire des patients sous traitement antirétroviral à Ségou (Mali)
Author(s) : A. Maiga, B. Jarrousse, I. Haidara, L. Tegna, G. Carcelain, B. Autran, C. Katlama, le comité thérapeutique de Ségou et le groupe de travail Solthis
Download the posterEvaluation des enfants de moins de 5 ans nés de mères séropositives incluses dans l'INAARV
Author(s) : R. Abdoulaye-Mamadou, G.M. Lawal, A. Soumana, A. Gali-Yaroh, I. Adéossi, A. Harakoye, A. Diatta, M. Idé, Saïdou, C. Dézé, le comité médical technique du Niger et le groupe de travail Solthis
Download the poster
Pour un accès gratuit et décentralisé aux antirétroviraux en Afrique subsaharienne : l'expérience de Solthis dans la région de Ségou, au MaliAuthor(s) : E. Klement, Z. Traoré, B. Jarrousse, L. Tegna, C. Tétrel, C. Katlama
Le stockage ou l’accès technique est strictement nécessaire dans la finalité d’intérêt légitime de permettre l’utilisation d’un service spécifique explicitement demandé par l’abonné ou l’utilisateur, ou dans le seul but d’effectuer la transmission d’une communication sur un réseau de communications électroniques.
Le stockage ou l’accès technique est nécessaire dans la finalité d’intérêt légitime de stocker des préférences qui ne sont pas demandées par l’abonné ou l’utilisateur.
Le stockage ou l’accès technique qui est utilisé exclusivement à des fins statistiques.Le stockage ou l’accès technique qui est utilisé exclusivement dans des finalités statistiques anonymes. En l’absence d’une assignation à comparaître, d’une conformité volontaire de la part de votre fournisseur d’accès à internet ou d’enregistrements supplémentaires provenant d’une tierce partie, les informations stockées ou extraites à cette seule fin ne peuvent généralement pas être utilisées pour vous identifier.
Le stockage ou l’accès technique est nécessaire pour créer des profils d’utilisateurs afin d’envoyer des publicités, ou pour suivre l’utilisateur sur un site web ou sur plusieurs sites web à des fins de marketing similaires.